Back to Search Results

The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patients

Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada.

Kidney International. 2003;64((1):):295-304.

Full text from:

Study details

Study Design : Economic Study

Credits : Bibliographic data from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine